Spadafora L - Search Results

1

Functional Mitral Regurgitation in the Transcatheter Era: Diagnostic and Therapeutic Pathways.

Di Muro FM, Spadafora L, Buonpane A, Leuzzi F, Nardi G, Bossone E, Biondi Zoccai G, Attisano T, Meucci F, Di Mario C, Vecchione C, Galasso G. Di Muro FM, et al. Among authors: spadafora l. J Pers Med. 2025 Aug 13;15(8):372. doi: 10.3390/jpm15080372. J Pers Med. 2025. PMID: 40863434 Free PMC article. Review.

2

The cardiologist's commandment: Thou shalt not retract!

Spadafora L, Testa A, Frati G, Biondi-Zoccai G. Spadafora L, et al. Int J Cardiol. 2022 Mar 1;350:106-108. doi: 10.1016/j.ijcard.2022.01.016. Epub 2022 Jan 11. Int J Cardiol. 2022. PMID: 35026341 No abstract available.

3

Juvenile myocardial infarction: Sex matters.

Bernardi M, Spadafora L, Biondi-Zoccai G, Giordano A. Bernardi M, et al. Among authors: spadafora l. Int J Cardiol. 2022 Aug 15;361:18-19. doi: 10.1016/j.ijcard.2022.05.046. Epub 2022 May 23. Int J Cardiol. 2022. PMID: 35618105 No abstract available.

4

Coronary artery bypass grafting added to surgical aortic valve replacement in octogenarians.

Spadafora L, Bernardi M, Biondi-Zoccai G, Frati G. Spadafora L, et al. Interact Cardiovasc Thorac Surg. 2022 Jul 9;35(2):ivac191. doi: 10.1093/icvts/ivac191. Interact Cardiovasc Thorac Surg. 2022. PMID: 35876811 Free PMC article. No abstract available.

5

Imatinib as a Tool Against COVID-19: A Balancing Act Between Effectiveness and Cardiac Safety.

Spadafora L, Bernardi M, Biondi-Zoccai G, Peruzzi M. Spadafora L, et al. J Cardiovasc Pharmacol. 2022 Dec 1;80(6):779-780. doi: 10.1097/FJC.0000000000001356. J Cardiovasc Pharmacol. 2022. PMID: 35998027 No abstract available.

6

Should We Consider Recombinant Human Brain Natriuretic Peptide to Prevent Postoperative Atrial Fibrillation?

Bernardi M, Spadafora L, Biondi-Zoccai G. Bernardi M, et al. Among authors: spadafora l. J Cardiovasc Pharmacol. 2023 Jan 1;81(1):18-20. doi: 10.1097/FJC.0000000000001375. J Cardiovasc Pharmacol. 2023. PMID: 36214698 No abstract available.

7

Magnitude of Low-density Lipoprotein Reduction and Impact on Major Cardiovascular Outcomes.

Giordano S, Spadafora L, Biondi-Zoccai G, Bernardi M. Giordano S, et al. Among authors: spadafora l. J Cardiovasc Pharmacol. 2023 Jan 1;81(1):15-17. doi: 10.1097/FJC.0000000000001376. J Cardiovasc Pharmacol. 2023. PMID: 36214705 No abstract available.

8

Step-wise Lipid-Lowering Therapy: Thinking Beyond the Guidelines.

Pingitore A, Spadafora L, Biondi-Zoccai G, Giordano A. Pingitore A, et al. Among authors: spadafora l. J Cardiovasc Pharmacol. 2023 Feb 1;81(2):114-116. doi: 10.1097/FJC.0000000000001388. J Cardiovasc Pharmacol. 2023. PMID: 36410033 No abstract available.

9

Which future for aspirin in acute coronary syndromes treated with percutaneous coronary intervention? An overview on aspirin-free strategies.

Spadafora L, Bernardi M, Galli M, Biondi-Zoccai G, Sabouret P. Spadafora L, et al. Arch Med Sci. 2022 Nov 7;18(6):1689-1692. doi: 10.5114/aoms/155411. eCollection 2022. Arch Med Sci. 2022. PMID: 36457983 Free PMC article. No abstract available.

10

De-escalation of antiplatelet therapy in patients with coronary artery disease: Time to change our strategy?

Sabouret P, Spadafora L, Fischman D, Ullah W, Zeitouni M, Gulati M, De Rosa S, Savage MP, Costabel JP, Banach M, Biondi-Zoccai G, Galli M. Sabouret P, et al. Among authors: spadafora l. Eur J Intern Med. 2023 Apr;110:1-9. doi: 10.1016/j.ejim.2022.12.008. Epub 2022 Dec 25. Eur J Intern Med. 2023. PMID: 36575107 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

98 results

Search Page

Filters